Glenmark Pharmaceuticals Inc., USA recalls Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray, 665 mcg/25 mcg per spray, 240 Metered Sprays/b
Recalled October 9, 2024 · FDA recall D-0006-2025 · Glenmark Pharmaceuticals Inc., USA
Hazard
Defective Delivery System: The dip tube is clogged causing the spray not to work. · FDA Class II
Units
45,504 bottles
Sold at
Nationwide in the USA
Description
Defective Delivery System: The dip tube is clogged causing the spray not to work.
Product
Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray, 665 mcg/25 mcg per spray, 240 Metered Sprays/bottle, 29 g net fill weight, Distr. by Hikma Specialty USA Inc., Columbus, OH 43328, hikma, Glenmark Specialty SA. NDC 59467-700-27.
Manufacturer(s)
Glenmark Pharmaceuticals Inc., USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →